Nuclear power reactors stand out at dusk. Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Bannerman Energy (ASX:BMN) has completed a Scoping Study assessing potential expansion options for its flagship Etango Uranium project in Namibia.

The authors of the study ultimately looked at two routes to ‘expand’ the project – by increasing throughput capacity to 16Mtpa, or, by extending LOM from 15 years to 27 years.

The company’s given these two possible expansion methods their own names – “Etango-XP” and “Etango-XT” respectively.

The “XP” plan for Etango – a boost to throughput – would cost Bannerman US$325M and see a sustaining cost of US$42.5/lb.

The “XT” plan, meanwhile – increasing LOM – would have no capex requirements and would see the sustaining cost slightly higher at US$45.3/lb.

The company cited a potential 95.2Mlbs of ore being part of that plan but did not include any resource information in its scoping study release on Monday.

“In short, the long-term scalability of the world-class Etango resource remains highly robust under the base case Etango-8 approach to initial project development,” Bannerman Chief Executive Officer Gavin Chamberlain said of the proposed plans.

Executive Chair Brandon Munro made it clear that the company is eyeing higher uranium prices.

“What the Scoping Study emphatically evidences is the significant underlying value residing in Etango’s huge in-ground leverage to, and scalability with, higher uranium price outlooks,” Munro said.

Post-tax IRR remained largely the same across both scenarios.

BMN shares last traded at $3.16/sh.

bmn by the numbers
More From The Market Online

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk
The Market Online Video

Introducing Prairie Lithium: Saskatchewan’s permitted lithium project ready to scale

We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's…
The Market Online Video

US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27

AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and
The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre.